These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 11605663

  • 1. Evaluation of flow properties of dry powder inhalation of salbutamol sulfate with lactose carrier.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Leuenberger H.
    Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1326-30. PubMed ID: 11605663
    [Abstract] [Full Text] [Related]

  • 2. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Inagaki Y, Todo H, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):938-42. PubMed ID: 15304985
    [Abstract] [Full Text] [Related]

  • 3. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):444-6. PubMed ID: 15056961
    [Abstract] [Full Text] [Related]

  • 4. Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):350-3. PubMed ID: 14993760
    [Abstract] [Full Text] [Related]

  • 5. Effect of surface covering of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenbergerb H.
    Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1455-7. PubMed ID: 14646332
    [Abstract] [Full Text] [Related]

  • 6. Preparation of dry powder inhalation with lactose carrier particles surface-coated using a Wurster fluidized bed.
    Iida K, Todo H, Okamoto H, Danjo K, Leuenberger H.
    Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):431-4. PubMed ID: 15802846
    [Abstract] [Full Text] [Related]

  • 7. [Effect of mixing of fine carrier particles on dry powder inhalation property of salbutamol sulfate (SS)].
    Iida K, Leuenberger H, Fueg LM, Müller-Walz R, Okamoto H, Danjo K.
    Yakugaku Zasshi; 2000 Jan; 120(1):113-9. PubMed ID: 10655787
    [Abstract] [Full Text] [Related]

  • 8. [Effect of separation characteristics between salbutamol sulfate (SS) particles and model carrier excipients on dry powder for inhalation].
    Iida K, Leuenberger H, Fueg LM, Müller-Walz R, Danjo K.
    Yakugaku Zasshi; 1999 Oct; 119(10):752-62. PubMed ID: 10518459
    [Abstract] [Full Text] [Related]

  • 9. Preparation of dry powder inhalation by surface treatment of lactose carrier particles.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Leuenberger H.
    Chem Pharm Bull (Tokyo); 2003 Jan; 51(1):1-5. PubMed ID: 12520118
    [Abstract] [Full Text] [Related]

  • 10. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
    Faulhammer E, Wahl V, Zellnitz S, Khinast JG, Paudel A.
    Int J Pharm; 2015 Aug 01; 491(1-2):231-42. PubMed ID: 26136200
    [Abstract] [Full Text] [Related]

  • 11. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM, MacRitchie HB, Marriott C, Martin GP.
    Int J Pharm; 2007 Mar 21; 333(1-2):45-55. PubMed ID: 17064863
    [Abstract] [Full Text] [Related]

  • 12. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
    Kaialy W, Martin GP, Larhrib H, Ticehurst MD, Kolosionek E, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2012 Jan 01; 89():29-39. PubMed ID: 21962946
    [Abstract] [Full Text] [Related]

  • 13. Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.
    Kaialy W, Ticehurst MD, Murphy J, Nokhodchi A.
    J Pharm Sci; 2011 Jul 01; 100(7):2665-84. PubMed ID: 21268026
    [Abstract] [Full Text] [Related]

  • 14. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J, Gill C, Young PM, Traini D.
    Curr Drug Deliv; 2015 Jul 01; 12(1):40-6. PubMed ID: 25146438
    [Abstract] [Full Text] [Related]

  • 15. Elucidating the Effect of Fine Lactose Ratio on the Rheological Properties and Aerodynamic Behavior of Dry Powder for Inhalation.
    Sun Y, Qin L, Li J, Su J, Song R, Zhang X, Guan J, Mao S.
    AAPS J; 2021 Apr 15; 23(3):55. PubMed ID: 33856568
    [Abstract] [Full Text] [Related]

  • 16. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W, Ticehurst M, Nokhodchi A.
    Int J Pharm; 2012 Feb 28; 423(2):184-94. PubMed ID: 22197772
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P, Du J, Smyth HDC.
    J Pharm Sci; 2017 Jan 28; 106(1):366-376. PubMed ID: 27939234
    [Abstract] [Full Text] [Related]

  • 18. Quantification of the surface morphologies of lactose carriers and their effect on the in vitro deposition of salbutamol sulphate.
    Heng PW, Chan LW, Lim LT.
    Chem Pharm Bull (Tokyo); 2000 Mar 28; 48(3):393-8. PubMed ID: 10726864
    [Abstract] [Full Text] [Related]

  • 19. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
    Chan LW, Lim LT, Heng PW.
    J Pharm Sci; 2003 May 28; 92(5):975-84. PubMed ID: 12712417
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.
    Du P, Du J, Smyth HD.
    AAPS PharmSciTech; 2014 Dec 28; 15(6):1417-28. PubMed ID: 24962007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.